This report contains personal medical information. Please enter the access password to continue.
Tanita Pro Body Composition • Recomposition & GLP-1 Microdosing Review • Baseline 6 June 2026
Tirzepatide (Mounjaro / Zepbound) is a once-weekly injection that activates two gut hormones, GLP-1 and GIP. The standard obesity protocol climbs to 10–15 mg/week. Microdosing is different: you hold a deliberately low dose — typically 1.25–2.5 mg/week — for the metabolic and appetite benefits without the aggressive, muscle-stripping weight loss of full doses. For someone in your position — not obese, already muscular, looking to recompose — a low steady dose is the sensible fit: it quietens the “food noise”, makes a modest deficit effortless, and improves how you handle carbohydrate, while you keep training and eating protein.
You start from a genuinely good place: high muscle, a young metabolic age, perfect symmetry, and visceral fat just inside the healthy band. The plan is simple and entirely within reach — add resistance training with an upper-body bias, trim 5–7 kg of central fat (a low-dose GLP-1 makes it easy), eat 160–180 g of protein, and send us your bloods so we can make this precise. Re-scan in 90 days and we expect to see the arms up, the trunk down, and that metabolic age heading into your mid-30s.